- International Manufacturer of Human Protein Medicines Selects the Leader in Revenue Management for Greater Accuracy and Efficiencies in Provider Intelligence and Management
Model N, Inc., the leader in cloud revenue management solutions, announced that specialty manufacturer Octapharma USA, Inc. has selected the Model N Revenue Management Cloud for Life Sciences, including Model N’s Provider Management and Provider Intelligence applications, as its revenue management system of record. Working diligently to combat the worldwide COVID-19 pandemic through the development of plasma derived blood product therapies, fast-growing Octapharma USA will leverage the Model N solution as part of an overall reengineering of its legacy, manually-based revenue management processes.
We are focused on delivering ROI for our customers, no matter their size or scale, and the capabilities that Model N brings to companies of all sizes are designed and built to help them achieve critical business objectives.
Octapharma USA’s parent company, Octapharma AG, is headquartered in Lachen, Switzerland, and is the largest privately-owned and independent plasma fractionator in the world. Octapharma creates medicines from high-quality human proteins sourced from human plasma and human cell lines, focusing on hematology, immunotherapy and critical care therapeutic areas. The company will use the Model N platform to achieve greater accuracy, create new efficiencies, and scale in support of Octapharma’s overall growth.
Recommended AI News: Hot Startups : Latest News And Updates On Daily Roundup
“We are excited about the potential of the Model N solution as part of our business initiatives around capturing any potential lost revenue, particularly as it relates to working with our distributor partners,” said Louis DiCriscio, senior vice president of finance and operations for Octapharma USA. “We anticipate that Model N’s cloud-based revenue management tools will help make our gross-to-net revenue processes faster and more precise, which will result in both cost savings and increased revenues over the long term.”
Octapharma’s selection of the Model N solution is typical of the growing need for solutions like Revenue Cloud for enterprise manufacturers in the life sciences, pharma and medtech markets. Numerous companies face the same challenges in this segmentation of the market – including the need to drive topline revenue, reduce revenue leakage, manage complicated pricing and reimbursement schemes, and ensure regulatory compliance – and the scalable, cloud-based Model N solution offers a range of powerful capabilities at a reasonable cost.
Recommended AI News: Cloudera Appoints Gary Hu to Board of Directors
“We’re gratified that Octapharma has recognized the Model N solution for its power and flexibility, as well as its suitability in terms of price and performance,” said Melonie Warfel, vice president and general manager, life sciences for ModelN. “We are focused on delivering ROI for our customers, no matter their size or scale, and the capabilities that Model N brings to companies of all sizes are designed and built to help them achieve critical business objectives.”
Recommended AI News: Hall of Fame CIO Paul Martin Joins Ping Identity’s Board of Directors
To get more details click here.
